<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page2_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page2_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>16</o:Revision>
  <o:TotalTime>247</o:TotalTime>
  <o:Created>2005-08-31T16:48:00Z</o:Created>
  <o:LastSaved>2005-09-02T17:38:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>576</o:Words>
  <o:Characters>3285</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>27</o:Lines>
  <o:Paragraphs>6</o:Paragraphs>
  <o:CharactersWithSpaces>4034</o:CharactersWithSpaces>
  <o:Version>9.6926</o:Version>
 </o:DocumentProperties>
</xml><![endif]-->
<style>
<!--
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-font-kerning:16.0pt;}
h2
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:14.0pt;
	font-family:Arial;
	font-style:italic;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-next:Normal;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	color:navy;
	font-weight:bold;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1029"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/"
title="To the InterPro database"><span style='font-size:9.0pt;font-family:Arial;
color:black;text-decoration:none;text-underline:none'><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:141pt;
 height:45pt'>
 <v:imagedata src="./Page2_files/image001.jpg" o:title="InterPro"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=188 height=60
src="./Page2_files/image002.jpg" v:shapes="_x0000_i1025"><![endif]></span></a></p>

<p class=MsoCaption>Cholera Toxin</p>

<p class=MsoNormal><b><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></b></p>

<div align=center>

<table border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;
 mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td width=568 style='width:426.1pt;background:#CCCCCC;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal align=center style='text-align:center'><b><!--[if gte vml 1]><v:shape
   id="_x0000_i1028" type="#_x0000_t75" style='width:239.25pt;height:239.25pt'>
   <v:imagedata src="./Page2_files/image003.jpg" o:title="cholera_mechanism"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=319 height=319
  src="./Page2_files/image004.jpg" v:shapes="_x0000_i1028"><![endif]><o:p></o:p></b></p>
  </td>
 </tr>
 <tr>
  <td width=568 valign=top style='width:426.1pt;background:#F3F3F3;padding:
  0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b>Action of cholera toxin.</b><span style="mso-spacerun:
  yes">  </span>See below for description.<span style="mso-spacerun: yes"> 
  </span>A, B (cholera toxin subunits); GM1 (GM1 ganglioside receptor); G<sub>s</sub><span
  style='font-family:Symbol'>a</span> (G protein); AC (adenylate cyclase); G<sub>i</sub>
  (G protein); cAMP (cyclic AMP); CFTR (cystic fibrosis transmembrane
  conductance regulator).</p>
  <p class=MsoNormal><span style='font-size:9.0pt;mso-bidi-font-size:12.0pt'>Reprinted
  from Trends Pharmacol Sci. 26, J. R. Thiagarajah and A. S. Verkman, <i>New
  Drug Targets for Cholera Toxin</i>, PP. 172-5, 2005, <a
  href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15808339&amp;query_hl=1"
  title="JR Thiagarajah and AS Verkman (2005) Trends Pharmacol Sci 26 PP.172-5, New Drug Targets for Cholera Therapy">PMID:
  15808339</a><o:p></o:p></span></p>
  </td>
 </tr>
</table>

</div>

<p class=MsoNormal><b><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></b></p>

<p class=MsoNormal><b><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></b></p>

<h2><span style='color:navy;font-style:normal'>The Actions of Cholera Toxin<o:p></o:p></span></h2>

<p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>When
cholera toxin is released from the bacteria in the infected intestine, it binds
to the intestinal cells known as enterocytes (epithelial cell in above diagram)
through the interaction of the pentameric B subunit of the toxin with the GM1
ganglioside receptor on the intestinal cell, triggering endocytosis of the
toxin.<span style="mso-spacerun: yes">  </span>Next, the A/B cholera toxin must
undergo cleavage of the A1 domain from the A2 domain in order for A1 to become
an active enzyme.<span style="mso-spacerun: yes">  </span>Once inside the
enterocyte, the enzymatic A1 fragment of the toxin A subunit enters the
cytosol, where it activates the G protein G<sub>s</sub><span style='font-family:
Symbol'>a</span> through an ADP-ribosylation reaction that acts to lock the G
protein in its GTP-bound form, thereby continually stimulating adenylate
cyclase to produce cAMP.<span style="mso-spacerun: yes">  </span>The high cAMP
levels activate the cystic fibrosis transmembrane conductance regulator (CFTR),
causing a dramatic efflux of ions and water from infected enterocytes, leading
to watery diarrhoea.<span style="mso-spacerun: yes">  </span></p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>One
area of anti-diarrhoea treatment lies in the stimulation of enkephalins, which
regulate intestinal secretion by acting directly on enterocytes.<span
style="mso-spacerun: yes">  </span>Enkephalins bind to the opioid receptors on
enterocytes, which act through G proteins to inhibit the stimulation of cAMP
synthesis induced by cholera toxin, thereby directly controlling ion transport.
</p>

<p class=MsoNormal><span style='mso-bidi-font-size:10.0pt;color:blue'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<h2><span style='color:navy;font-style:normal'>Diversity in Cholera Strains<o:p></o:p></span></h2>

<p class=MsoNormal><span style='mso-bidi-font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=MsoNormal style='text-align:justify'><span style='mso-bidi-font-size:
10.0pt'><span style='mso-tab-count:1'>            </span>The effects of cholera
involve the actions of other <i>Vibrio cholerae</i> toxins that aid the
pathogen in its colonisation, coordinated expression of virulence factors, and
toxin action.<span style="mso-spacerun: yes">  </span>These additional proteins
include </span>zona occludens toxin (<i>zot</i>, involved in <i>Vibrio cholerae</i>
invasion by acting to decrease intestinal tissue resistance), accessory cholera
toxin (<i>ace</i>, increases fluid secretion), toxin-coregulated pilus (<i>tcpA</i>,
<span style='mso-bidi-font-size:10.0pt'>essential colonisation factor and
receptor for the CTX</span><span style='mso-bidi-font-size:10.0pt;font-family:
Symbol'>f</span><span style='mso-bidi-font-size:10.0pt'> phage</span>), NAG-specific
heat-labile toxin (<i>st</i>), and outer membrane porin proteins (<i>ompU</i>
and <i>ompT</i>).<span style="mso-spacerun: yes">  </span>The expression of
virulence factors is controlled by the transcriptional factors ToxR, TcpP and
ToxT.<span style="mso-spacerun: yes">  </span>Different strains of <i>Vibrio
cholerae</i> produce differing sets and amounts of these auxiliary toxins,
which in turn affect the clinical symptoms of cholera and its responsiveness to
treatment.<span style="mso-spacerun: yes">  </span></p>

<p class=MsoNormal style='text-align:justify;text-indent:36.0pt'>For example,
the cholera outbreak in Russia in 1942 was caused by the El Tor biotype strain
of <i>Vibrio cholerae</i>, rather than the classical biotype that caused the pandemics
in the 19<sup>th</sup> and early 20<sup>th</sup> centuries.<span
style="mso-spacerun: yes">  </span>The El Tor biotype can carry several extra copies
of CTX<span style='font-family:Symbol'>f</span> bacteriophage that contains the
toxin genes ctxAB (encodes cholera toxin A and B subunits), zot (encodes zona occludens
toxin) and ace (encodes accessory cholera toxin), leading to an increase in
cholera toxin production.<span style="mso-spacerun: yes">  </span>The El Tor
biotype can also produce haemolysin, which is capable of lysing red blood cells
by attacking their membranes.<span style="mso-spacerun: yes">  </span>In
addition, unlike the classical biotype, the El Tor biotype generates novel
toxin strains through CTX<span style='font-family:Symbol'>f</span> phage
conversion.<span style="mso-spacerun: yes">  </span>These El Tor strains
produce different, milder clinical symptoms, with many patients showing asymptomatic
cholera not accompanied by dehydration.<span style='mso-bidi-font-size:10.0pt'><o:p></o:p></span></p>

<p class=MsoNormal><span style='mso-bidi-font-size:10.0pt;color:blue'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<h1 align=center style='text-align:center'><span style='font-size:14.0pt;
mso-bidi-font-size:16.0pt'>Next:<span style="mso-spacerun: yes">  </span><span
style='color:blue'><a href="Page3.htm">What InterPro Tells Us</a></span><o:p></o:p></span></h1>

<h1 align=center style='text-align:center'><span style='font-size:14.0pt;
mso-bidi-font-size:16.0pt'>Previous:<span style="mso-spacerun: yes">  </span><a
href="Page1.htm">Cholera Toxin, the Main Culprit</a><o:p></o:p></span></h1>

<p class=MsoNormal><span style='color:blue'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

</div>

</body>

</html>
